Monoclonal Antibodies: Leading Actors in the Relapsed/Refractory Multiple Myeloma Treatment

Multiple myeloma is a complex hematologic malignancy, and despite a survival improvement related to the growing number of available therapeutic options since 2000s, it remains an incurable disease with most patients experiencing relapse. However, therapeutic options for this disease are constantly e...

Descripción completa

Detalles Bibliográficos
Autores principales: Morè, Sonia, Petrucci, Maria Teresa, Corvatta, Laura, Fazio, Francesca, Offidani, Massimo, Olivieri, Attilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760536/
https://www.ncbi.nlm.nih.gov/pubmed/33260960
http://dx.doi.org/10.3390/ph13120426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760536/
https://www.ncbi.nlm.nih.gov/pubmed/33260960
http://dx.doi.org/10.3390/ph13120426

Ejemplares similares